Zoekresultaten - 3 results

Low hepatitis C prevalence in Belgium: implications for treatment reimbursement and scale up.

in order to guide decisions on DAA  reimbursement. METHODS: Residual sera were collected through clinical laboratories. We collected data on age, sex and district. HCV antibody status was determined ...

Diagnostic hepatitis C testing of people in treatment for substance use disorders in Belgium between 2011 and 2014: a cross-sectional study.

are scarce, and particularly for people who inject drugs. The current study refines the existing HCV estimates by focussing on diagnostic HCV testing practices for this population at risk. METHODS: The ...

Estimates of people who injected drugs within the last 12 months in Belgium based on a capture-recapture and multiplier method

capture-recapture harm reduction hidden population multiplier method People who inject drugs treatment Abstract: Background For Belgium, available estimates of the number of people who inject drugs (PWID) are based ...

QR code

QR code for this page URL